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Abstract 
Background: A new generation of IRS insecticides which can provide improved and prolonged control of pyre-
throid-resistant malaria vector populations are being developed. Fludora® Fusion is a new IRS insecticide containing a 
mixture of deltamethrin and clothianidin, a neonicotinoid.
Methods: The efficacy of Fludora® Fusion IRS was evaluated over 11–12 months on concrete and mud substrates 
in laboratory bioassays and experimental huts against wild free-flying pyrethroid-resistant Anopheles gambiae (sensu 
lato) in Cové, Benin. A comparison was made with the two active ingredients of the mixture; clothianidin and del-
tamethrin, applied alone. CDC bottle bioassays were also performed to investigate resistance to clothianidin in the 
wild vector population.
Results: Fludora® Fusion induced > 80% laboratory cone bioassay mortality with both susceptible and pyrethroid-
resistant An. gambiae (s.l.) for 7–9 months on concrete block substrates and 12 months on mud block substrates. The 
vector population at the experimental hut site was fully susceptible to clothianidin in CDC bottle bioassays. Overall 
mortality rates of wild free-flying pyrethroid-resistant An. gambiae (s.l.) entering the experimental huts during the 
11-month trial were < 15% with deltamethrin and significantly higher with Fludora® Fusion (69–71%) and clothianidin 
alone (72–78%). Initial high experimental hut mortality rates with Fludora® Fusion (> 80%) only declined by 50% after 
8 months. Monthly in situ wall cone bioassay mortality of susceptible mosquitoes was > 80% for 9–12 months with 
Fludora® Fusion and clothianidin alone. Fludora® Fusion induced significantly higher levels of early exiting of mosqui-
toes compared to clothianidin alone (55–60% vs 37–38%, P < 0.05).
Conclusions: Indoor residual spraying with Fludora® Fusion induced high and prolonged mortality of wild pyre-
throid-resistant malaria vectors for 7–10 months mostly due to the clothianidin component and substantial early 
exiting of mosquitoes from treated huts due to the pyrethroid component. Fludora® Fusion is an important addi-
tion to the current portfolio of IRS insecticides with the potential to significantly reduce transmission of malaria by 
pyrethroid-resistant mosquito vectors. 
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Background
Indoor residual spraying remains a core strategy in the 
fight against malaria due to its ability to rapidly reduce 
transmission [1]. It constitutes the application of a resid-
ual insecticide to potential resting surfaces of malaria 
vectors; usually the inner walls, ceiling and eaves of 
human habitats and domestic animal shelters. There 
has been a substantial increase in the use of IRS over the 
last two decades [2, 3] and this has contributed signifi-
cantly to reductions in malaria morbidity and mortality 
observed in many endemic countries [4]. The effective-
ness of IRS for malaria vector control however depends 
on several factors; mainly the continued susceptibility of 
local vectors to the insecticides deployed and the dura-
tion of its action on treated home wall substrates. For 
some decades, IRS relied heavily on a rather limited num-
ber of classes of insecticides [2, 3] most of which were 
short-lived on home wall substrates (2–5  months) thus 
requiring multiple resource-demanding IRS campaign 
rounds when used in areas with stable malaria transmis-
sion [5]. Malaria vectors have also developed resistance 
to these conventional insecticides which is now wide-
spread and increasing in intensity across Africa [6] and 
this, together with their short residual effect is driving 
the development of a new generation of long-lasting IRS 
insecticides to which local vectors are largely susceptible.
The neonicotinoid, clothianidin is a new repurposed 
insecticide which was recently added to the WHO’s list 
of pre-qualified insecticides for use in indoor residual 
spraying [7]. Clothianidin presents a new mode action 
which differs from that of conventional public health 
insecticides acting as an agonist on nicotinic acetylcho-
line receptors (nAChR) [8]. Owing to its novel mode of 
action, it shows potential to provide improved control 
of vector populations that have developed resistance to 
older public health insecticides. The addition of clothi-
anidin to the portfolio of IRS insecticides also provides 
an opportunity to mitigate the development and spread 
of insecticide resistance in malaria vectors through 
the rotational use of IRS insecticides and the develop-
ment of mixture IRS co-formulations [9]. Insecticide 
mixtures for IRS need to be explored with new public 
health insecticides when they become available because 
mixtures have the dual potential to improve malaria 
vector control through the combined effect of both 
active ingredients and contribute to insecticide resist-
ance management, especially in areas where resistance 
to both active ingredients is not yet established [10].
In a previous experimental hut study in Benin, a tank 
mix of clothianidin and deltamethrin induced high and 
prolonged mortality (8–9  months) in wild pyrethroid-
resistant An. gambiae (s.l.) owing to the clothianidin 
component and early exiting of mosquitoes from exper-
imental huts due to the pyrethroid component [11]. 
The encouraging results from this early proof of con-
cept study led to the development of Fludora® Fusion 
(Bayer CropScience, Monheim, Germany), a new IRS 
formulation of a wettable powder product containing 
500 g/kg of clothianidin and 62.5 g/kg of deltamethrin 
in water-soluble sachets. In the present study, the effi-
cacy of Fludora® Fusion was evaluated against pyre-
throid-resistant An. gambiae (s.l.) in southern Benin 
under both laboratory and experimental hut condi-
tions. Its residual effect was assessed on mud and con-
crete wall substrates. A comparison was made with the 
two active ingredients of the mixture; clothianidin and 
deltamethrin, applied alone.
Methods
Laboratory evaluation
Preparation and treatment of block substrates
Concrete and mud blocks used for the laboratory bio-
assays were formed in 9 cm Petri dishes and dried at 
27 ± 2 °C and 80 ± 10% RH for 30 days before insecti-
cide application. Concrete blocks were made by mixing 
cement with sand at a 1:1 ratio while mud blocks were 
made from local mud paste to which 10% cement was 
added to improve its hardness, in line with local prac-
tices. These substrates were treated using a potter tower 
sprayer to achieve a homogeneous and accurate deposit 
of the target concentration of active ingredient per unit 
area. Blocks were weighed before and after treatment 
to ensure the target insecticide volume was delivered. 
All treated blocks were stored, unsealed at 30 ± 2 ℃, 
80 ± 10% RH in between bioassays. Four replicate blocks 
of each substrate were treated with each of the following 
insecticides: Fludora® Fusion WP at 200 mg + 25 mg/m2; 
Clothianidin WG at 200 mg/m2; and Deltamethrin WG 
at 25 mg/m2.
Keywords: Clothianidin, Mixtures, Indoor residual spraying, Fludora® Fusion, Pyrethroid resistance, Malaria vectors, 
Fludora, Formulations, Anopheles, Cové, IRS block substrates, Neonicotinoids, IRS mixtures, Experimental huts, Vector 
control, Mosquito control
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Residual efficacy on treated block substrates
Residual efficacy of the insecticides on the treated mud 
and concrete block substrates were assessed in monthly 
cone bioassays following WHO guidelines [12]. Forty (40) 
2–5-day-old laboratory maintained susceptible Anoph-
eles gambiae Kisumu and pyrethroid-resistant Anoph-
eles gambiae (s.l.) Cové mosquitoes were exposed for 
30 min to each treatment and substrate in replicates of 
10 mosquitoes per block. The laboratory cone bioassays 
were conducted at monthly intervals for up to 12 months. 
Based on the delayed effect of clothianidin on mosquito 
mortality as demonstrated in previous studies [11], mor-
tality was recorded every 24 hours up to 120 hours post-
exposure across all experiments.
Experimental hut trial
Study site and experimental huts
The hut trial was performed at the CREC/LSHTM exper-
imental hut station in Cové, Southern Benin. The field 
site is located in an irrigated valley producing rice almost 
year-round and providing suitable breeding habitats for 
mosquitoes. The rainy season extends from March to 
October and the dry season from November to Febru-
ary. The vector population consists of both An. coluzzii 
and An. gambiae (sensu stricto) with the latter occurring 
at lower frequencies (~23%) and mostly in the dry season 
[13]. The vector population is highly resistant to pyre-
throids. Molecular genotyping and microarray studies 
have demonstrated a high frequency of the L1014F allele 
(> 90%) and overexpression of the cytochrome P450s 
CYP6P3, associated with pyrethroid detoxification [13]. 
The trial ran for 11 months between December 2015 and 
November 2016 in 7 experimental huts of West African 
design. The experimental huts are made from concrete 
bricks with a corrugated iron roof. Inner walls were plas-
tered with either concrete or mud and the ceilings fitted 
with palm thatch matting. Each hut was built on a con-
crete plinth surrounded by a water-filled moat to prevent 
the entry of scavenging ants and had a wooden framed 
veranda trap to capture exiting mosquitoes. Mosquito 
entry occurred via four window slits each measuring 1 
cm and situated on three sides of the hut.
Susceptibility of wild vector population to clothianidin
CDC bottle bioassays were performed to investigate the 
susceptibility of the Cové vector population to clothia-
nidin. Wild pyrethroid-resistant An. gambiae Cové adult 
mosquitoes which emerged from larvae collected from 
breeding sites within the experimental hut site were 
exposed to 250 ml Wheaton bottles treated with clothia-
nidin at 90 µg/bottle and deltamethrin at 12.5 µg/bottle. 
Stock solutions were prepared using a mixture of acetone 
and 81% rapeseed oil (methyl ester) in the ratio of 2:3 as 
a solvent for clothianidin and acetone alone for deltame-
thrin. Four replicate bottles were prepared per insecticide 
and approximately 100 2–5-days-old F1 wild pyrethroid-
resistant An. gambiae (s.l.) Cové were tested against each 
insecticide in replicates of 25 mosquitoes per bottle. The 
CDC bottle bioassay protocol was modified; mosquitoes 
were exposed for 2 h after which they were transferred 
to observation cups and knockdown recorded 1 h after 
exposure and mortality after every 24 h for up to 120 h. 
Tests were also performed with the susceptible An. gam-
biae Kisumu strain for comparison.
Experimental hut treatments
The following insecticides were tested in the experimen-
tal huts: (i) Fludora® Fusion Wettable Powder containing 
500 g/kg clothianidin + 62.5 g/kg deltamethrin (Bayer 
CropScience, Germany); (ii) K-Othrine Water Dispers-
ible Granule containing 250 g/kg deltamethrin (Bayer 
CropScience, Germany); (iii) Clothianidin Water Dis-
persible Granule containing 700 g/kg (Bayer CropSci-
ence, Germany).
The following treatments and application rates were 
compared in 7 experimental huts: (i) Unsprayed hut 
(control)–concrete-walled hut; (ii) Deltamethrin applied 
at 25 mg/m2–concrete-walled hut; (iii) Deltamethrin 
applied at 25 mg/m2–mud-walled hut; (iv) Clothianidin 
applied at 200 mg/m2–concrete-walled hut; (v) Clothian-
idin applied at 200 mg/m2–mud-walled hut; (vi) Fludora® 
Fusion applied at 200 mg + 25 mg/m2–concrete-walled 
hut; and (vii) Fludora® Fusion applied at 200 mg + 25 mg/
m2– mud-walled hut.
The walls and ceiling of each experimental hut were 
sprayed using a Hudson X-pert compression sprayer. 
To improve spraying accuracy, spray swaths were pre-
marked on hut walls and a guidance pole was attached to 
the end of the spray lance to maintain a fixed distance to 
the wall.
Assessing spray quality
Before spraying, filter papers (Whatman No 1) measur-
ing 5 × 5 cm were fixed on each hut wall using mask-
ing tape. After spraying, the filter papers were removed, 
carefully packaged in Aluminium foil and stored at 4 
℃ for about 2 weeks after which they were shipped to 
BioGenius GmBH, Germany, for chemical analysis to 
assess the quality of the spray applications using gas 
chromatography.
Hut trial procedure
The trial followed the WHO guidelines for evaluation of 
IRS products [12]. Treatments were randomly allocated 
to experimental huts. Seven consenting adult human vol-
unteers slept in the huts from 21:00 to 5:00 h each trial 
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night to attract mosquitoes and were rotated between 
huts on successive nights to adjust for variation in indi-
vidual attractiveness to mosquitoes. In the morning, 
mosquitoes were collected from the room and veranda 
using aspirators and brought to the laboratory where 
they were identified and scored as fed or unfed and dead 
or alive. Live mosquitoes were provided with 10% glucose 
solution and mortality scored every 24 h for up to 120 h.
Outcome measures
The efficacy of each experimental hut treatment was 
expressed in terms of the following outcome measures: 
(i) Exiting rates (the proportion of mosquitoes collected 
in the veranda); (ii) Blood-feeding rates (the proportion 
of blood-fed mosquitoes); and (iii) Mortality (the pro-
portion of mosquitoes found dead after a 120 h holding 
time).
Residual activity of insecticide treatments
To assess the residual activity of the treatments on the 
treated experimental hut walls, WHO cone bioassays 
were conducted using 2–5-day-old, female mosqui-
toes of the insecticide susceptible An. gambiae Kisumu 
strain. Bioassays were performed 3 days after applica-
tion of treatments and at monthly intervals thereafter 
over 12 months. A total of 50 mosquitoes were tested per 
hut in cohorts of 10 per cone on each treated wall/ceil-
ing surface. Mosquitoes were exposed to treated surfaces 
for 30 min following WHO guidelines [12]. Mortality was 
recorded every 24 h up to 120 h post-exposure.
Data analysis
Experimental hut data were entered in Excel and trans-
ferred to Stata 15.1 for analysis. Proportional data (exit-
ing rate, blood-feeding and mortality) were analysed 
using logistic regression while adjusting for the effects of 
sleeper attractiveness to mosquitoes. Cone bioassay mor-
tality was pooled for each treatment and substrate at each 
time point and compared against an 80% cut-off criteria 
following WHO guidelines [12].
Results
Laboratory cone bioassay results
Mortality of susceptible An. gambiae Kisumu and pyre-
throid-resistant An. gambiae (s.l.) Cové strains in labo-
ratory cone bioassays with control untreated mud and 
concrete blocks did not exceed 20% at any time point 
(Figs.  1 and 2). For both types of substrates, mortal-
ity rates for each treatment were generally higher/more 
persistent with the Kisumu strain compared to the pyre-
throid-resistant Cové strain. Mortality with deltame-
thrin-treated blocks was > 80% for the first 2–4  months 
with the susceptible Kisumu strain after which it 
declined sharply (Figs.  1a and 2a), but with pyrethroid-
resistant Cové strain, mortality on both substrate-types 
did not exceed 50% at any time point (Figs. 1b and 2b). 
On concrete blocks, mortality with clothianidin was 
> 80% for 7  months with the susceptible Kisumu strain 
(Fig.  1a) and only 2 months with the pyrethroid-resist-
ant Cové strain (Fig.  1b). Meanwhile, Fludora® Fusion 
induced more residual mortality on concrete blocks 
which remained > 80% for 9 months with the suscepti-
ble Kisumu strain (Fig. 1a) and 7 months with the pyre-
throid-resistant Cové strain (Fig. 1b). With mud blocks, 
mortality rates with clothianidin and Fludora® Fusion 
were very stable remaining above 90% for both mosquito 
strains for up to 12 months (Fig. 2).
Experimental hut results
Susceptibility of vector population to clothianidin
Results from the CDC bottle bioassays are presented in 
Fig. 3. Mortality rates with the control were less than 10% 
even up to 120 h post-exposure. Knockdown and mor-
tality of wild F1 An. gambiae (s.l.) mosquitoes emerging 
from larvae collected from the Cové experimental hut 
site were respectively 52% and 39% with deltamethrin-
treated bottles thus confirming the levels of pyrethroid 
resistance in the Cové vector population. With clothia-
nidin-treated bottles, knockdown and mortality after 24 
h were respectively 98% and 100%, demonstrating full 
susceptibility to the insecticide. Meanwhile, with the sus-
ceptible An. gambiae Kisumu strain, mortality was > 95% 
at 24 h with both insecticides. More detailed results on 
CDC bottle bioassays are available in the supplementary 
information (Additional file 1: Table S1).
Mosquito entry and exiting
The experimental hut results are summarised in 
Table  1. A total of 57,518 wild free-flying pyrethroid-
resistant female An. gambiae (s.l.) mosquitoes were 
collected in the experimental huts over the 11-month 
trial indicating an average of 8217 mosquitoes per hut 
(Table 1). For both concrete and mud-walled huts, exit-
ing rates with deltamethrin (62–64%) and Fludora® 
Fusion (55–60%) was significantly higher than the con-
trol hut (40%) and clothianidin-only huts (37–38%) 
(P < 0.05). The exiting rates observed with Fludora® 
Fusion-treated huts are therefore attributable to the 
deltamethrin component in the mixture. Blood-feeding 
rates were high across all insecticide treatments tested 
(87–92%); hence, there was no evidence of blood-feed-
ing inhibition with any of these treatments regardless of 
the wall substrate (Table 1).
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Mortality rates
Mortality rates of wild free-flying pyrethroid-resistant 
An. gambiae (s.l.) which entered the experimental huts 
during the 11-month trial are presented in Table  1 and 
Figs. 4, 5.
Overall mortality rates. Overall mortality was 4% in the 
control hut and 12–15% in the deltamethrin IRS-treated 
huts. Overall mortality in Fludora® Fusion (69–70%) and 
clothianidin-sprayed huts (72–78%) was significantly 
higher than in deltamethrin-treated huts (12–15%; 
P < 0.001). Clothianidin-sprayed huts however killed sig-
nificantly larger proportions of mosquitoes compared 
to Fludora® Fusion (P < 0.05). As observed in laboratory 
bioassays, mortality rates with all insecticide treatments 
were generally higher in mud-walled huts compared to 
concrete-walled huts (P < 0.01), nevertheless, the actual 
differences were generally small (1–6 units).
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Fig. 1 Monthly mortality of susceptible Anopheles gambiae Kisumu (a) and pyrethroid-resistant Anopheles gambiae (s.l.) Cové (b) exposed to 
insecticide-treated concrete block substrates in WHO cone bioassays. Each data point represents monthly mortality 120 h post-exposure
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Fig. 2 Monthly mortality of susceptible Anopheles gambiae Kisumu (a) and pyrethroid-resistant Anopheles gambiae (s.l.) Cové (b) exposed to 
insecticide-treated mud block substrates in WHO cone bioassays. Each data point represents monthly mortality 120 h post-exposure
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Delayed mortality. Figure  5 presents the mortal-
ity rates of wild pyrethroid-resistant An. gambiae (s.l.) 
in the experimental huts recorded every 24 h up to 120 
h. Mortality with the control was < 2% after 24 h and 
increased to only 4% after 120 h. For both types of wall 
substrates, Fludora® Fusion and clothianidin alone dem-
onstrated a substantial increase in delayed mortality with 
the numbers of days after collection from the treated 
huts. Mortality in huts treated with clothianidin and 
Fludora® Fusion increased steadily from approximately 
20–25% after 24 h to 69–78% after 120 h. This trend was 
not strongly expressed in huts treated with deltamethrin 
alone where mortality did not exceed 20% after 120 h for 
both substrate types, thus demonstrating that the delayed 
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Fig. 3 Susceptibility of wild pyrethroid-resistant An. gambiae (s.l.) from Cové to clothianidin in CDC bottle bioassays. ~ 100 2–5-days-old mosquitoes 
of each strain were exposed to each insecticide in 4 replicate bottles. Error bars represent 95% confidence intervals
Table 1 Experimental hut results for wild free-flying pyrethroid-resistant An. gambiae (s.l.) entering IRS-treated experimental huts in 
Cové, Benin
Notes: Values bearing the same superscript letter along a column are not significantly different at the 5% level (P > 0.05, logistic regression)
Wall type Hut treatment Total collected %Exiting (95% CI) %Blood fed (95% CI) %Mortality 
(120 h) (95% 
CI)
Concrete walls Control 10,917 40 (39–41)a 87 (86–88)a 4 (3–4)a
Deltamethrin (25 mg/m2) 8674 62 (61–63)b 91 (90–92)b 12 (11–13)b
Clothianidin (200 mg/m2) 8040 38 (37–39)c 90 (89–91)bc 72 (71–73)c
Fludora® Fusion (200 mg/m2) 8149 60 (59–61)d 91 (90–91)bd 69 (68–70)d
Mud walls Deltamethrin (25 mg/m2) 6632 64 (62–65)b 92 (91–93)e 15 (15–16)e
Clothianidin (200 mg/m2) 6290 37 (36–38)c 89 (88–90)cd 78 (77–79)f
Fludora® Fusion (200 mg/m2) 8562 55 (54–56)e 87 (86–88)a 70 (69–71)g
a
b
d f
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e
g
0
20
40
60
80
100
Control Deltamethrin 25 Clothianidin 200 Fludora Fusion 200 + 25
Concrete-walled huts
Mud-walled huts
Fig. 4 Overall mortality (%) of wild pyrethroid-resistant An. gambiae 
(s.l.) entering IRS-treated experimental huts in Cové, Benin. Each 
bar represents mortality over 11 months. Bars bearing the same 
letter label are not significantly different at the 5% level (P > 0.05, 
logistic regression). Error bars represent 95% confidence intervals. 
Abbreviations: Delta, deltamethrin; Cloth, clothianidin
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mortality effect observed with Fludora® Fusion is largely 
due to the clothianidin component of the mixture.
Residual efficacy of IRS treatments
Monthly mortality of wild mosquitoes. Figure  6 shows 
monthly mortality rates of wild free-flying, pyrethroid-
resistant An. gambiae (s.l.) entering IRS-treated experi-
mental huts over 11 months for both concrete and 
mud-walled huts. For both substrates, Fludora® Fusion 
and clothianidin killed at least 80% of wild, pyrethroid-
resistant An. gambiae (s.l.) entering experimental huts 
for the first 4 months, after which mortality declined 
progressively to < 40% after 9 months. Conversely, the 
proportion of wild pyrethroid-resistant An. gambiae (s.l.) 
killed in the deltamethrin-treated huts did not exceed 
25% throughout the trial.
Cone bioassay mortality on treated hut walls Quarterly 
mortality rates (pooled for every 3 months) of the suscep-
tible, laboratory-maintained An. gambiae Kisumu strain 
following exposure to mud and concrete IRS-treated 
experimental hut walls in in situ cone bioassays are pre-
sented in Fig.  7. Cone bioassay mortality on control 
untreated hut walls did not exceed 5% for all four quar-
ters. With deltamethrin-treated huts, cone bioassay mor-
tality was > 80% only for the first 3 months after which 
it declined sharply. Cone bioassay mortality remained 
> 80% for 9 months with Fludora® Fusion and 12 months 
with clothianidin on concrete-walled huts and 12 months 
with both insecticides on mud-walled huts.
Quality of IRS applications
The results from chemical analysis of filter papers per-
formed at BioGenius GmBH, Germany, are presented in 
Table 2. The average AI content in filter papers for each 
treatment and wall substrate type were within an accept-
able deviation of 22% from the target dose showing that 
the treatments were correctly applied.
Discussion
This study evaluated the efficacy of Fludora® Fusion, 
a clothianidin and deltamethrin mixture, for indoor 
residual spraying in laboratory studies and in an experi-
mental hut trial against a vector population in Benin 
which is highly resistant to pyrethroids. The low mor-
tality response with deltamethrin IRS in the experimen-
tal huts is very typical of studies conducted in this area 
of Benin [11, 14] thus demonstrating the redundancy of 
solo pyrethroid products for IRS and further highlighting 
the need for novel non-pyrethroid IRS insecticides. Stud-
ies performed with Fludora® Fusion in West Africa have 
so far reported its efficacy on treated surfaces only in 
cone bioassays [15, 16] which generally do not take into 
consideration the behaviour of vector mosquitoes. Our 
study demonstrates for the first time the efficacy of Flu-
dora® Fusion against wild free-flying pyrethroid-resistant 
malaria vectors in household settings in Benin. At all lev-
els of evaluation, Fludora® Fusion clearly showed greatly 
improved and prolonged overall mortality of pyrethroid 
susceptible and resistant strains of An. gambiae (s.l.) 
compared to deltamethrin on both mud and concrete 
substrates. The results confirm previous findings across 
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Africa [11, 15, 16], thus demonstrating the suitability of 
Fludora® Fusion for indoor residual spraying in Benin 
and other malaria-endemic areas which are characterised 
by high intensities of pyrethroid resistance in local mos-
quito vectors.
One rationale for the use of a mixture of insecticides 
in the Fludora® Fusion IRS formulation over clothianidin 
alone is the possibility to achieve greater levels of vec-
tor control through the combined effects of both active 
ingredients. In laboratory cone bioassays with concrete 
block substrates, Fludora® Fusion showed longer resid-
ual activity compared to clothianidin alone. This was 
surprisingly more evident with the pyrethroid-resistant 
strain where mortality was > 80% for five months with 
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huts in Cové, Benin. Each bar represents % mortality (120 h) over each successive month of the trial for treatments applied in concrete and 
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Fludora® Fusion-treated concrete blocks compared to 
only one month with clothianidin. This suggests a syn-
ergistic action of both insecticides with the mixture in 
cone bioassays which appeared not to be affected by the 
pyrethroid-resistant status of the mosquito strain. This 
effect was however not observed in experimental huts; 
mortality rates of wild pyrethroid-resistant mosqui-
toes were higher in huts treated with clothianidin alone 
compared to Fludora® Fusion; though this was only by a 
few units. The difference in outcome could be attributed 
to differences in mosquito behaviour in reaction to the 
insecticides in cone bioassays compared to experimental 
huts. Contrary to cone bioassays where mosquito move-
ment is very limited, mosquitoes enter experimental huts 
ad libitum and feed on the sleeper before resting on the 
IRS-treated walls to pick up the IRS treatment. There-
fore, the high excito-repellent effect of deltamethrin in 
Fludora® Fusion could have prevented mosquitoes from 
resting long enough on the treated hut walls to pick up 
adequate amounts of clothianidin in the mixture IRS thus 
leading to reduced overall mortality rates compared to 
clothianidin.
Previous experimental hut studies also showed sig-
nificantly reduced mortality with an IRS mixture of 
chlorfenapyr and alpha-cypermethrin compared to chlo-
rfenapyr alone (43% vs 63% [14] and 18–22% vs 38–46% 
[17]) which was also attributed to the irritant effect of 
the pyrethroid in the mixture. Alternatively, the small 
difference in performance between Fludora® Fusion and 
clothianidin-solo IRS in huts could also be due to differ-
ences in the types of IRS formulations (WG for clothiani-
din and WP for Fludora® Fusion) as has been previously 
reported with some pyrethroid IRS insecticides [18, 19]. 
However, contrary to the chlorfenapyr and alpha-cyper-
methrin mixture, the mortality achieved with Fludora® 
Fusion was only a few points lower than that of clothia-
nidin alone (70–71% vs 72–78%) and this is less expected 
to result in operationally significant differences in the 
impact on clinical malaria when used in IRS campaigns. 
Also, the high insecticide induced exiting rate observed 
with Fludora® Fusion compared to clothianidin alone in 
this study and previously [11] is important for reducing 
indoor resting and biting which may contribute to lower-
ing transmission intensities.
While a universal diagnostic dose for clothianidin is 
yet to be established for malaria vectors, our results 
showed full susceptibility to clothianidin in CDC bot-
tle bioassays at 90 µg/bottle in a vector population that 
is highly resistant pyrethroids [13]. Recent studies in 
neighbouring countries in West Africa also reported 
full susceptibility to clothianidin [20, 21] at even lower 
doses [21] in pyrethroid-resistant malaria vectors 
despite high levels of resistance to other neonicoti-
noids widely used in agriculture in the region [21]. As 
new active ingredients are introduced into the pub-
lic health portfolio of insecticides, strategies to delay 
the development of resistance to these insecticides in 
malaria vectors must be taken into consideration before 
large-scale use in order to extend their useful life [9]. 
Modelling studies have suggested that the use of an 
insecticide in a mixture especially when it is effective 
at killing mosquitoes, has potential to prompt slower 
evolution of resistance to the insecticide compared to 
when it is used alone [22]. Considering its effectiveness, 
the co-formulation of clothianidin into the Fludora® 
Fusion mixture might be a better option for delaying 
the development and spread of resistance to clothiani-
din in malaria vectors compared to formulations with 
clothianidin alone. Further studies to investigate this 
hypothesis under large scale use would be necessary.
Contrary to a previous study in Benin [15], we observed 
a longer residual effect of Fludora® Fusion on mud walls 
compared to concrete surfaces. This could be attributed 
to the addition of a small amount of cement in the mud 
paste used for moulding the blocks and wall plaster used 
in our study. Previous studies examining the content of 
mud from Cové, Benin, demonstrated a high silt content 
which makes it less suitable for construction (unpub-
lished data). The addition of a small amount of cement is 
in line with a common local practice in Benin and other 
Table 2 Chemical analysis of filter papers from IRS-treated experimental huts in Cové, Benin (mean insecticide content)
Abbreviation: RSD, relative standard deviation
Hut treatment Wall type Clothianidin content 
(mg/m2)
RSD (%) %Deviation Alpha content 
(mg/m2)
RSD (%) %Deviation
Deltamethrin Concrete – – – 21 54 16
Mud – – – 30 15 −20
Clothianidin Concrete 208 67 − 4 – – –
Mud 244 20 − 22 – – –
Fludora® Fusion Concrete 211 23 − 5.5 26 24 −4
Mud 186 23 7 23 8 8
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parts of Africa which is aimed at improving the durability 
and aesthetic of inner wall plastering in earthen houses 
[23]. This could have changed the characteristics of the 
mud substrates making them more stable, much less 
porous and more suitable for Fludora® Fusion compared 
to the traditional mud-plastered wall. This finding shows 
that Fludora® Fusion could be highly effective in semi-
urban and usually more populated areas in many African 
settings where the addition of cement to mud for con-
struction and plastering of earthen houses is becoming 
common [23].
Based on results from our studies and others, Flu-
dora® Fusion was added to the WHO’s list of pre-
qualified IRS formulations for vector control becoming 
the first IRS insecticide to contain a mixture of active 
ingredients [7]. Fludora® Fusion was recently deployed 
for IRS in Benin by the National Malaria Control Pro-
gramme in the 2020 IRS campaign; studies to assess its 
impact under operational conditions are on-going.
Conclusions
Fludora® Fusion when applied for IRS induced high 
mortality against wild free-flying pyrethroid-resistant 
malaria vectors in Benin mostly due to the clothianidin 
component and early exiting due to the deltamethrin 
component. The insecticide also provided prolonged 
indoor mosquito vector control which lasted for 7–10 
months on both mud and concrete substrates. Fludora® 
Fusion proves to be an important addition to the cur-
rent portfolio of IRS insecticides.
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